Detalles de la búsqueda
1.
Afatinib versus erlotinib as second-line treatment of patients with advanced squamous cell carcinoma of the lung (LUX-Lung 8): an open-label randomised controlled phase 3 trial.
Lancet Oncol
; 16(8): 897-907, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-26156651
2.
Evaluation of the VeriStrat® serum protein test in patients with advanced squamous cell carcinoma of the lung treated with second-line afatinib or erlotinib in the phase III LUX-Lung 8 study.
Lung Cancer
; 109: 101-108, 2017 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-28577938
3.
Effectiveness of transbronchial needle aspiration in the diagnosis of exophytic endobronchial lesions and submucosal/peribronchial diseases of the lung.
Lung Cancer
; 50(2): 221-6, 2005 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-16046029
4.
Smoking and prognostic factors in an observational setting in patients with advanced non-small cell lung carcinoma.
J Cancer
; 2: 52-61, 2011 Jan 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-21234301
Resultados
1 -
4
de 4
1
Próxima >
>>